- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The current unmet needs in the female contraceptives market are similar to those that were present 10 years ago. Currently, marketed contraceptives carry the risk of irregular bleeding patterns, weight gain, changes in mood, depression, migraine or headache, nausea, and acne. Side effects are one of the main reasons why patients may decide to discontinue […]
Carmot acquisition propels Roche to forefront of obesity drug leadership, finds GlobalData
In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion. This strategic acquisition provides Roche access to Carmot’s portfolio, which notably includes three lead molecules, all GLP-1 analogues, currently in the advanced stages of clinical trials for obesity and type 2 diabetes. […]
Influencers on X opine ETFs will enhance Bitcoin’s credibility among investors, reveals GlobalData
Over a decade after the first application, the US Securities and Exchange Commission (SEC) has approved all 11 applications for spot bitcoin (Exchange Traded Funds (ETFs), which is a significant development for the cryptocurrency industry. In line with this, social media discussions (‘X’ platform) around “Bitcoin” spiked up 90% over the last seven days, reveals […]
Top 50 APAC firms gain over $337 billion in MCap in Q4 2023, reveals GlobalData
With China’s reopening, strong domestic demand in India and Indonesia, and better-than-expected earnings, the top 50 firms in the Asia-Pacific (APAC) region witnessed an increase in their aggregate market capitalization (MCap) by more than $337 billion in the final quarter (Q4) of 2023, reveals GlobalData, a leading data and analytics company. Companies from the financial […]
GlobalData’s Technology Foresights reveals Sony headset launched at CES 2024 competes head-to-head with Apple’s Vision Pro
The opening day of CES 2024 witnessed a flurry of product launches, notably Sony Corp’s surprising entry into the mixed reality headset arena. Tailored for spatial content creators, the headset is anticipated to hit the market later this year. Simultaneously, Apple revealed that its flagship spatial computing headset, the Vision Pro, showcased last year, will […]
Amgen may potentially compete with established leaders in obesity, says GlobalData
On January 8, Amgen presented at JP Morgan’s 42nd Annual Healthcare Conference 2024 (JPM24), highlighting their pillars of business. One of these pillars was the general medicine franchise, which entailed the obesity space. The company has two promising pipeline agents in development for obesity that address the unmet needs of improved efficacy, faster weight loss, […]
AbbVie’s Produodopa holds potential to become first-choice pump for advanced Parkinson’s, says GlobalData
Following the news that AbbVie has launched Produodopa (foscarbidopa/foslevodopa), to treat severe motor fluctuations in patients with advanced Parkinson’s disease (PD) in the European Union (EU). Christie Wong, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “AbbVie’s Produodopa is the first-to-market subcutaneous infusion of levodopa. Produodopa uses a VYAFUSER pump […]
Top 25 global banks see 11.1% QoQ growth in MCap during Q4 2023, reveals GlobalData
Al Rajhi Banking and Charles Schwab witness over 25% growth each China Merchants Bank loses over 10% JPMorgan Chase consistently tops the table for the last seven quarters The aggregate market capitalization (MCap) of the top 25 global banks grew by 11.1% to $3.61 trillion quarter-on-quarter (QoQ) during the fourth quarter (Q4) ended on 31 […]
Biotech funding recovery is on the horizon in 2024, says GlobalData
Over 2022 and 2023, biotech funding saw significant change, with a marked downturn in investment. Hoverer, the post-pandemic slump is expected to end with the market heading to recovery in 2024, finds GlobalData, a leading data and analytics company. A recent GlobalData’s survey “The State of the Biopharmaceutical Industry 2024” found that overall, more than […]
Xiaomi’s foray into automotives anticipated by Technology Foresights platform, reveals GlobalData
During the recent holiday season, Xiaomi made headlines by unveiling its first electric car, the SU7, which is set to enter production later in 2024. In a surprising move, the company also announced plans to continue investing in research and development (R&D) of electric vehicles (EVs) with the aim of securing a spot among the […]
MDD market across 8MM to reach $9.6bn by 2029 driven by novel drug launches, says GlobalData
The major depressive disorder (MDD) market is forecast to grow from $4.7 billion in 2019 to $9.6 billion by 2029 across the eight major markets (8MM*) at a compound annual growth rate (CAGR) of 7.4%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Major Depressive Disorder: Eight-Market Drug Forecast and Market […]
Enterprises must navigate through challenges to ensure responsible and ethical deployment of AI solutions, says GlobalData
Generative AI has raised new challenges related to ‘Responsible AI’, catapulting concerns into the headlines and forcing enterprises to revisit their AI policies at a time when they investigate new potential applications. Enterprises need to ensure that AI solutions are implemented in a responsible and ethical way, says GlobalData, a leading data and analytics company. […]
Threat actors tap social engineering and AI to drive more cyber attacks in 2024, says GlobalData
A major trend in cybersecurity is the speed and adeptness with which hackers adapt their techniques to take advantage of technological advances. Attacks leveraging social engineering have become more frequent and more expensive in 2023. The profitability and the ease with which social engineering-related cyber attacks are launched will drive an even higher volume of […]
Addressing unmet needs of bronchiectasis key to develop effective treatments, says GlobalData
Although not a common disease, bronchiectasis has been in the spotlight of research as no therapies have been approved for its treatment. Bronchiectasis is a disease characterised by the abnormal enlargement of the bronchi in the lungs and the overproduction of mucus, which results in a poor quality of life, with physicians urging for improved […]
India’s fight against rare diseases needs more focus on awareness and diagnosis, says GlobalData
In November 2023, the Indian Union Health Ministry authorised the sale of four generic medications for the treatment of rare diseases. This approval is a significant milestone in the fight against rare diseases in India. These approved indigenous products, along with other products yet to be approved, will aid patients suffering from rare diseases. However, […]
Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData
Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by GlobalData, a leading data and analytics company. The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of […]
Telecom and pay-TV services revenue in South Korea to increase at 10.3% CAGR over 2023-28, forecasts GlobalData
The telecom and pay-TV services revenue in South Korea is forecast to increase at a compounded annual growth rate (CAGR) of 10.3% during 2023-2028, supported by strong growth in the mobile data segment, according to GlobalData, a leading data and analytics company. GlobalData’s South Korea Telecom Operators Country Intelligence Report reveals that the mobile data […]
Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData
Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, exagamglogene autotemcel (Casgevy). However, given that 88% of CRISPR drugs are in the early stages of development, it is unlikely to see another CRISPR approval any time soon, says GlobalData, a leading data and analytics company. In November […]
Portugal general insurance industry to surpass $9 billion by 2028, says GlobalData
The Portuguese general insurance industry is set to grow at a compound annual growth rate (CAGR) of 6.9% from EUR6.6 billion ($6.7 billion) in 2023 to EUR9.2 billion ($9.7 billion) in 2028, in terms of gross written premiums (GWP), forecasts GlobalData, a leading data and analytics company. GlobalData’s Insurance Database reveals that the Portuguese general […]
APAC heavy trucks market to expand at 4.9% CAGR over 2023-28, forecasts GlobalData
The increasing pace of global industrialization is driving a surge in demand for heavy trucks. The Asia-Pacific (APAC) region, serving as a prominent global industrial hub, is experiencing a substantial demand for heavy trucks. Notably, China is anticipated to lead the growth in the heavy truck market within the region, with India and Japan following […]